Skip to main content

Peer Review reports

From: APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer

Original Submission
10 Oct 2023 Submitted Original manuscript
25 Nov 2023 Reviewed Reviewer Report - Nicholas Adzibolosu
27 Nov 2023 Reviewed Reviewer Report
8 Jan 2024 Author responded Author comments - Dongmei Zhou
25 Jan 2024 Author responded Author comments - Dongmei Zhou
Resubmission - Version 2
8 Jan 2024 Submitted Manuscript version 2
1 Feb 2024 Author responded Author comments - Dongmei Zhou
Resubmission - Version 3
1 Feb 2024 Submitted Manuscript version 3
2 Feb 2024 Author responded Author comments - Dongmei Zhou
Resubmission - Version 4
2 Feb 2024 Submitted Manuscript version 4
22 Feb 2024 Author responded Author comments - Dongmei Zhou
Resubmission - Version 5
22 Feb 2024 Submitted Manuscript version 5
2 Mar 2024 Author responded Author comments - Dongmei Zhou
Resubmission - Version 6
2 Mar 2024 Submitted Manuscript version 6
Publishing
11 Mar 2024 Editorially accepted
21 Mar 2024 Article published 10.1186/s12885-024-12105-z

You can find further information about peer review here.

Back to article page